The overexpression of CD44 in this cancer is an early event during carcinogenesis initiation, which is responsible for the acquisition of a senescence-resistant phenotype and the accumulation of mutations by hepatocytes undergoing transformation25. The gene discussed is CD44; the disease is cancer.